Information Letter on NeuroBloc® (botulinum toxin type B): Risks related to "off-label“ use
2013.02.25
Active substance: botulinum toxin type B
Serious adverse events were observed in connection with NeuroBloc® if used outside the licensed indication ("off-label“).
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN